Invokana contains the active substance canagliflozin which belongs to a group of medicines called "blood-glucose lowering drugs."
"Blood-glucose lowering drugs" are medicines used by adults to treat type 2 diabetes.
This medicine works by increasing the amount of sugar removed from the body in the urine. This reduces the amount of sugar in the blood.
Type 2 diabetes is a condition in which the body does not make enough insulin, and the insulin that the body produces does not work as well as it should. The body can also make too much sugar. When this happens, sugar (glucose) builds up in the blood. This can lead to serious medicinal conditions such as heart disease, kidney disease, blindness, and amputation.